Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease

Coronary Artery Disease

Volumn 8, Issue 5, 1997, Pages 253-258

  Güvener, Nilgün ^a,b   Aytemir, Kudret ^a   Aksöyek, Serdar ^a   Gedik, Olcay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Coronary artery disease; Endothelin 1; Non insulin dependent diabetes mellitus

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VASCULAR DISEASE;

EID: 0030803590     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199705000-00001     Document Type: Article

References (50)

1. Stout RW: Diabetes and atherosclerosis - the role of insulin. Diabetologia 1979, 16:141-150.
2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women. Ann Int Med 1977, 87:393-397.
3. Krolewski AS, Warram JH, Valsania P, Martin BC, Leffel LM, Christlieb AR: Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991, 9 (suppl 2A):56-61.
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y: A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
5. Battistini B, Chailler P, D'Orleans P, Briere N, Sirois P: Growth regulatory properties of endothelins. Peptides 1993, 14:385-399.
6. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y: ET stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988, 238:249-252.
7. Hirata Y, Takagi Y, Fukuda Y: ET is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989, 78:225-228.
8. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 1990, 267:16-18.
9. Takahashi K, Ghatei M, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990, 33:306-310.
10. Yau-Jiunn Lee, Shi-Jang Shin, Juei-Hsiung Tsai: Increased urinary endothelin-1 like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 1994, 17:263-266.
11. Kanno K, Hirata Y, Shichiri M, Marumo F: Plasma endothelin levels in patients with diabetes mellitus with or without vascular complication. J Cardiovasc Pharmacol 1991, 17 (suppl 7):475-476.
12. Wolpert HA, Steen SN, Istfan NW, Simonson DC: Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993, 42:1027-1030.
13. Harrison F, Ellis RL, Ren-ming Hu, Ali Pedram: Insulin stimulates endothelin binding and action on altered vascular smooth muscle cells. Endocrinology 1993, 133:1092-1097.
14. Ren-ming Hu, Ellis RL, Ali Pedram, Harrison JL: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993, 42:351-358.
15. Krolewski AS, Kojinski EJ, Warram JH, et al.: Magnitude and determinants of coronary artery disease in juvenile onset insulin dependent diabetes mellitus. Am J Cardiol 1987, 59:750-755.
16. Pyorola K, Laokso M, Uusitupa M: Diabetes and atherosclerosis. An epidemiologic view. Diabetes Metab Rev 1987, 3:463-524.
17. Martin BC, Warram JH, Manson J, Krolewski AS: The excess risk of coronary artery disease with duration of diabetes mellitus. Diabetologia 1988, 31:518.
18. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF: Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992, 70:1191-1197.
19. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med 1986, 314:488-499.
20. Martin-Nizard F, Houssaini HS, Delattre SL, Duriez P, Fruchert JC.: Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 1991, 293:127-130.
21. Horio T, Kohno M, Yasunari K, Murakawa K, Yokokawa K, Ikeda M: Stimulation of ET-1 release by low density lipoproteins in cultured human endothelial cells. Atherosclerosis 1993, 101:185-190.
22. Weissberg PL, Witchell C, Dovenport AP, Hesketh TR, Metcalfe JC: The endothelin peptides ET-1, ET-2, ET-3 and safaratoxin S6b are comitogenic with PDGF for VSMC. Atherosclerosis 1990, 85:257-262.
23. Brown KD, Littlewood CJ: Endothelin stimulates DNA synthesis in Swiss 3T3 cells, synergy with polypeptide growth factors. Biochem J 1989, 263: 977-980.
24. Fabregat I, Rozengurt E: Vasoactive intestinal contractor, a novel peptide, shares a common receptor with endothelin-1 and stimulates mobilization and DNA synthesis in Swiss 3T3 cells. Biochem Biophys Res Commun 1990, 167:161-167.
25. Kusuhara M, Yamagushi K, Ohnishi A, Abe K, Klmura S, Oono H: Endothelin potentiates growth factor stimulated DNA synthesis in Swiss 3T3 cells. J Cancer Res 1989, 80:302-305.
26. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T: A novel vasoactive peptide stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 1989, 264:7856-7861.
27. Shichin M, Hirata Y, Nakajima T, Ando K, Imai T, Yanagisawa M: ET-1 is an autocrine/paracrine growth factor for human cancer cell lines. J Clin Invest 1991, 87:1867-1871.
28. MacGumber MW, Ross CA, Synder SH: Endothelin in brain: receptors, mitogenesis and biosynthesis in glial cells. Proc Natl Acad Sci USA 1990, 87:2359-2363.
29. Giaid A, Hamid OA, Springal DR, Yanagisawa M, Shinmi O, Sawamura T: Detection of endothelin immunoreactivity and mRNA in pulmonary tumors. J Pathol 1990, 162:15-22.
30. Kusuhara M, Yamagushi K, Nagasaki K, Hayashi C, Suzaki A, Hori S: Production of endothelin in human cancer cel lines. Cancer Res 1990, 50:3257-3261.
31. Schrey MP, Patel KV, Tezapsidis N: Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res 1992, 52:1786-1790.
32. Suzuki N, Matsumoto H, Kitada C, Kimura S, Fujino M: Production of ET-1 and big ET-1 by tumor cells with epithelial like morphology. J Biochem 1989, 106:736-742.
33. Nakaki T, Nakayama M, Yamamato S, Kato R: ET mediated stimulation of DNA synthesis in VSMC. Biochem Biophys Res Commun 1989, 158:880-883.
34. Hirata Y, Yashimi H, Takata S, Watanabe T, Kumagai S, Nakajima K: Cellular mechanism of action by a novel vasoconstrictor, endothelin, in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1988, 154:868-875.
35. Lopez- Farre A, Riesco A, Alvarez V, Egido J, Gallego MJ, Monton M: Endothelin stimulates human PMN adhesion to endothelial cells: regulation by cGMP. J Vasc Res 1992, 29:92-93.
36. Bertello P, Veglio F, Pinna G, Gurioli L, Molino P, Alban S: Plasma endothelin levels in NIDDM patients with and without complications. Diabetes Care 1994, 17:574-577.
37. Tomoh Masaki: Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Rev 1993, 14:256-268.
38. Yoshimato S, Ishizaki Y, Sasaki T, Murota S: Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991, 22:378-383.
39. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ: Polar secretion of endothelin by cultured endothelial cells. J Biol Chem 1992, 267:16066-16068.
40. Tanner FC, Boulanger CM, Luscher TF: Endothelium-derived nitric oxide, endothelin and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Sem Thromb Homeost 1993, 19:167-175.
41. Stewart DJ: Endothelin in cardiopulmonary disease: factor paracrine vs. neurohumoral. Eur Heart J 1993, 14 (suppl I):48-54.
42. Kiowski W, Lüsher TF, Linder L, Buhler FR: Endothelin-1 induced vasoconstriction in humans. Circulation 1991, 83:469-475.
43. Sakurai T, Goto K: Endothelins. Drugs 1993, 46:795-804.
44. Vanhoutte PM: Is endothelin involved in pathogenesis of hypertension. Hypertension 1993, 21:747-751.
45. Watanabe H, Suzuki N, Shimamoto N, Fujino M, Imada A: Endothelin in myocardial infarction [abstract]. Nature 1990, 344:114.
46. Lanviere R, Thibault G, Schiffrin EL, et al.: Increased ET-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993, 21:294-300.
47. Remuzzi R, Benigni A: Endothelins in the control of cardiovascular and renal function. Lancet 1993, 342:589-593.
48. Kawamura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K: Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 1992, 15:1396-1397.
49. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K: Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990, 119:801-806.
50. Qui S, Theroux P, Marcil M, Solymoss C: Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993, 82:12-19.